The anti-obesity drug boom may be cooling, as overall prescribing of GLP-1 medicines remained relatively flat for the three ...

Scientists discovered that people taking weight loss medications regained pounds weeks after they stopped taking the drugs. More than 1,000 people participated in a study and their lifestyle habits ...

The findings suggest weight loss drugs independently affect heart health risks, researchers said. View on euronews ...

Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much weight people lose while taking the drug, according to a new study led by a ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

WASHINGTON—The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed ...

"Given the escalating obesity rates, especially severe obesity among women, and the growing popularity of anti-obesity medications, exploring the association between anti-obesity medication and ...

With the supply of GLP-1 medications finally stabilizing as their use skyrocketed 600% among Americans from 2018 to 2024, the pharmaceutical landscape for anti-obesity medications is now poised to ...

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic. Hamlet Gasoyan, PhD, researcher at the ...

For 25 years, I’ve served as a rehabilitation counselor for the deaf at MassAbility, a state agency that helps individuals with disabilities find employment and live independently. I’m also the ...